10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Germ cell tumors: dose-intensive therapy.

      1 ,
      Seminars in oncology

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dose intensive chemotherapy in germ cell tumor patients has become a relatively safe procedure after the introduction of growth factors and the availability of autologous stem cells for hematopoietic rescue. Carboplatin and etoposide are the most active drugs available today, and are given in one or two subsequent cycles at dosages between 1000 and 2000 mg/m2 and 1200 and 2400 mg/m2, respectively. The potency of this approach is shown by the induction of long-term disease-free survival in a small proportion of patients with multiply relapsed or far advanced disease, deemed incurable with conventional chemotherapy. This observation indicates that cisplatin refractoriness can be overcome by high-dose carboplatin and etoposide. High-dose treatment (HDT) instituted earlier in the course of the disease, ie, for first-line salvage or even in first-line treatment of poor risk patients is better tolerated and is hoped to lead to superior tumor eradication. The value of HDT needs to be determined in randomized studies, some of which are under way.

          Related collections

          Author and article information

          Journal
          Semin. Oncol.
          Seminars in oncology
          0093-7754
          0093-7754
          Apr 1998
          : 25
          : 2
          Affiliations
          [1 ] Abt. für Innere Medizin und Poliklinik m.S. Hämatologie und Onkologie Virchow Klinikum, Humboldt Universität, Berlin, Germany.
          Article
          9562455
          74edb682-9ab9-4605-ac21-c3f51a50da45
          History

          Comments

          Comment on this article